Bulletin
Investor Alert

Cyclerion Therapeutics Inc.

NAS: CYCN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 1, 2023, 5:14 p.m.

/zigman2/quotes/207301221/composite

$

0.64

Change

-0.0012 -0.19%

Volume

Volume 8

Quotes are delayed by 20 min

/zigman2/quotes/207301221/composite

Today's close

$ 0.67

$ 0.64

Change

-0.03 -4.07%

Day low

Day high

$0.64

$0.72

Open

52 week low

52 week high

$0.35

$1.49

Open

Annual Financials for Cyclerion Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue --4.51M2.3M3.94M
Cost of Goods Sold (COGS) incl. D&A 1.75M1.53M--472,000
COGS excluding D&A -----
Depreciation & Amortization Expense 1.75M1.53M2.7M2.3M472,000
Depreciation 1.75M1.53M2.7M2.3M472,000
Amortization of Intangibles -----
Gross Income (1.75M)(1.53M)--3.47M
20172018201920202021 5-year trend
SG&A Expense 92.18M113.72M121.91M77.03M49.18M
Research & Development 78.8M87.72M95.14M56.41M37.64M
Other SG&A 13.37M26.01M26.77M20.62M-
Other Operating Expense -----
Unusual Expense --4.19M1.2M(405,000)
EBIT after Unusual Expense --(124.29M)(78.23M)(45.31M)
Non Operating Income/Expense --(751,000)429,000(6.34M)
Non-Operating Interest Income --2.03M--
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (93.92M)(115.25M)(123.01M)(77.8M)(51.65M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (93.92M)(115.25M)(123.01M)(77.8M)(51.65M)
Minority Interest Expense -----
Net Income (93.92M)(115.25M)(123.01M)(77.8M)(51.65M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (93.92M)(115.25M)(123.01M)(77.8M)(51.65M)
Preferred Dividends -----
Net Income Available to Common (93.92M)(115.25M)(123.01M)(77.8M)(51.65M)
EPS (Basic) (3.43)(4.21)(4.49)(2.56)(1.32)
Basic Shares Outstanding 27.4M27.4M27.38M30.4M39.14M
EPS (Diluted) (3.43)(4.21)(4.49)(2.56)(1.32)
Diluted Shares Outstanding 27.4M27.4M27.38M30.4M39.14M
EBITDA (92.18M)(113.72M)(117.4M)(74.74M)(45.24M)
Link to MarketWatch's Slice.